An Open Label, Single-Arm, Clinical Study to Evaluate the Safety and Efficacy of Anti-Dandruff Shampoo (HADS-022205) in healthy adult human subjects with dandruff.

Himalaya Wellness Company0 个研究点目标入组 116 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1) Subjects with dandruff determined by ASFS score 24 to 34 with itching and flaking.
•2) Subjects with visible flakes.
•3) Subjects with different hair types [normal, oily, dry, colored (synthetic and henna colored) and permed hair].
•4) Subjects willing to refrain from using other products on the scalp other than those provided, including other shampoos/conditioners, scalp and hair treatment and oils/ products that has anti-dandruff action during the study period.

•1) History of any dermatological conditions of the scalp (other than dandruff or seborrheic dermatitis) that would interfere with the diagnosis or assessment (e.g. psoriasis, eczema, atopic dermatitis, or other skin/scalp infections).
•2) Subjects with excessive erythema, crusting or a significant number of pustules/papules on the scalp.
•3) History of skin cancer or treatment for any type of cancer within the last 2 years.
•4) History of prior use of antidandruff treatment on scalp within past 1 month.

发起方